We are a top site for some of the most advanced radiopharmaceutical trials in the world. Explore innovative imaging opportunities and potentially life-saving therapies for diseases like prostate cancer, pancreatic cancer, small cell lung cancer, and many others. Clinical trial patients can expect the same exceptional care and attention as our standard treatment patients.
- Access to radiopharmaceutical imaging agents
- Access to radiopharmaceutical therapies
- Highest level of clinical safety practices
- Highest quality patient experience
- World-class Theranostics experts
- Complimentary on-site valet parking
BAMF Health is working every day to conduct additional clinical trials to improve disease management using molecular imaging and molecularly targeted radiation therapy.
Clinical Trial General Interest
If you are interested in learning more about participating in a clinical trial, please fill out this form.
Non-Hodgkin Lymphoma | Y-mAbs Therapeutics Therapy Patients with Non-Hodgkin Lymphoma will be treated with CD38-SADA:177Lu-DOTA complex.
Patients with non-Hodgkin Lymphoma will be treated with CD38-SADA:177Lu-DOTA complex (The treatment is a two-step radioimmunotherapy, delivered as two separate products CD38-SADA and 177Lu-DOTA) to establish optimal and safe therapeutic doses and dosing schedule of CD38-SADA, and 177Lu-DOTA.Patients with non-Hodgkin Lymphoma will be treated with CD38-SADA:177Lu-DOTA complex
Clinical Trial Updates
“Make Damn Sure You Get a PSA Test”
Jan says he had run out of treatment options for his metastatic prostate cancer, but what he heard when he came to BAMF was hope.
October 29, 2024
Radiopharm Theranostics and BAMF Health Announce Strategic Collaboration to Manufacture and Dose 18F-RAD 101 for Phase 2b Imaging Study of Brain Metastasis
BAMF Health will be a site for Radiopharma Theranostics’ clinical trial and will also be manufacturing 18F-RAD 101 for other trial sites.
October 21, 2024
BAMF Health Announces Strategic Clinical Trials Partnership with Adaptive Research
Partnership increases physician and patient participation in clinical trials
September 16, 2024